Cantuzumab mertansine Antibody
Cantuzumab mertansine is an antibody-drug conjugate (ADC) targeting CanAg, consisting of the huC242 monoclonal antibody linked to the cytotoxic agent DM1. It has demonstrated potent in vitro cytotoxicity against colon cancer cells and exhibits broad in vivo antitumor efficacy in CanAg-positive human tumor xenograft models.
Product Specifications
Target
Microtubule Associated, Antibody-Drug Conjugates (ADCs)
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Signal Transduction
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog